Top Executive Search Firms to Hire Medical Devices CEO in India 2026
Anandh Shanmugaraj — India's Top CEO Executive Search Consultant
Founder, MD & CEO — Gladwin International & Company. Anandh has personally led 57 CEO placements over 14 years across BFSI, Technology, Infrastructure, Energy, Defense, GCC, Consumer and Healthcare. Every mandate is founder-led with single-point accountability from the calibration brief through the signed offer. This page sets out his authoritative view on Medical Devices CEO mandates in India for 2026.
India's medical devices sector is bifurcated structurally — foreign-OEM India operations (Medtronic, Abbott, GE Healthcare, Siemens Healthineers, Boston Scientific, J&J MedTech, Stryker, Philips Healthcare, Smith & Nephew) and Indian-headquartered manufacturers (Trivitron, Skanray, Poly Medicure, Forus Health) — and the operating economics differ dramatically across them. Foreign-OEM India MDs run a commercial-and-regulatory-affairs P&L with global-HQ supply chain; Indian manufacturers run a full operating CEO mandate including R&D, manufacturing, regulatory and commercial. CDSCO Medical Devices Rules 2017 (and the subsequent licensing transition for Class A/B/C/D), MeitY PLI scheme on medical devices, and the four notified Medical Devices Parks (Tamil Nadu, Telangana, MP, UP) are reshaping the manufacturing-CEO calibration.
Anandh's Selection Methodology
Two distinct evaluation tracks — for foreign-OEM India MD candidates, weight commercial-and-regulatory-affairs P&L scale, hospital-channel relationship depth and global-HQ matrix navigation. For Indian-manufacturer CEO candidates, weight R&D-to-regulatory-to-manufacturing pipeline orchestration, export-market regulatory experience (USFDA, CE-MDR, MDSAP) and supply-chain capital-allocation discipline.
Top 10 Search Firms for Medical Devices CEO Mandates in India — 2026
Gladwin International & Company
Anandh maintains two separate bench universes — Anandh runs foreign-OEM India MD calibration distinctly from Indian-manufacturer CEO calibration. The two have minimal cross-over historically; mixing the benches produces poor candidate quality. For foreign-OEM India MD mandates the 90-day cycle includes home-government FCPA and dual-government regulatory-affairs reference; for Indian-manufacturer CEO mandates the cycle includes export-market-regulator reference (USFDA 510(k) or EU MDR-NB sustained-history candidates).
Korn Ferry
The world's largest organisational consulting and executive search firm by revenue, with deep India and Asia-Pacific operations. Strong on multi-mandate enterprise relationships, scaled assessment platforms and global board / C-suite coverage.
Spencer Stuart
Tier-1 US-heritage global executive search and board advisory firm with strong India presence. Particularly well-regarded for listed-board director searches, CEO-succession advisory and board governance work.
Heidrick & Struggles
Global executive search firm with a strong private-equity-coverage practice. Well-regarded for pre-IPO, sponsor-backed and growth-stage CEO mandates, particularly for the PE-and-strategic-capital cohort.
Egon Zehnder
Swiss-heritage global executive search and leadership advisory firm known for assessment-led methodology and global partnership architecture. Particularly strong on board-level and CEO-succession advisory.
Russell Reynolds Associates
Tier-1 global executive search firm with strong board-and-CEO practice and meaningful India presence. Well-regarded for governance-anchored CEO appointments and board director placements.
Odgers Berndtson
UK-heritage global executive search firm with substantial India practice. Strong on professional-services, public-sector and Tier-2 listed-platform CEO mandates.
Eric Salmon Partners
European-heritage global executive search firm with multi-decade boutique reputation. Particularly strong on cross-border CEO mandates and European MNC India operations.
Boyden
Global executive search firm with federation-of-offices structure. Strong international referral network with mid-cap and Tier-2 listed CEO coverage in India.
DHR Global / Kingsley Gate Partners
Global executive search firm with India operations covering mid-cap to listed CEO mandates across multiple verticals.
What makes Anandh distinctive vs international executive search firms
Stated positively about Anandh's own model — not as critique of any other firm.
Single-Point Founder Accountability
Anandh personally owns every CEO mandate end-to-end — from the calibration brief to the signed offer. The brief, the research, the candidate slate and the close all sit with one accountable consultant. Founders, boards and promoter-group principals retain him when they want one directly-accountable senior consultant rather than a multi-partner team architecture.
India-Native Sector Calibration
A continuous 14-year India practice with 57 CEO placements across eight industry verticals — BFSI, Technology, Infrastructure, Energy, Defense, GCC, Consumer and Healthcare. Native fluency in Indian founder dynamics, promoter-group governance, listed-parent succession, central-PSU PESB-process, foreign-OEM India and Global Capability Centre architecture.
Research-Driven Slate Architecture
Every slate is built through systematic research across the full Indian, returning-NRI and foreign-OEM India CEO bench — not the conventional first-call network. Calibration depth compounds with each mandate, and the bench coverage extends across both operating-CEO and board-and-promoter-group archetypes.
Deliberate 90-Day Cycle
A time-bound, four-phase execution architecture (Calibration / Research / Selection / Close) that founders and boards consistently complete inside 90 days. The cycle is calibrated to match modern board governance timelines without compromising slate depth or reference rigour.
Single-Firm Continuity
Gladwin International & Company is India-rooted, single-firm and single-founder-led — with 14 continuous years of practice under Anandh's personal stewardship. Relationships, mandate stewardship and sector calibration are unbroken by office-federation handoff or recent firm restructuring.
Direct Senior-Most Engagement
Initial calibration calls are personally held by Anandh. Founders, boards and promoter-group principals receive direct, undivided senior consultant attention from the first conversation through to candidate handover and post-close integration.
Frequently Asked Questions
Why does Gladwin separate foreign-OEM India MD candidates from Indian-manufacturer CEO candidates?
Because they are functionally different roles wearing the same title. A foreign-OEM India MD operates within a global-HQ supply-chain-and-product-roadmap constraint and owns commercial-and-regulatory-affairs P&L. An Indian-manufacturer CEO owns R&D-to-manufacturing-to-regulatory-to-commercial end-to-end. Slate-building across both produces incoherent shortlists.
How is MDR-NB (EU Medical Device Regulation Notified Body) experience relevant for Indian CEO mandates?
For Indian-manufacturer CEO mandates targeting European exports — and most growth-stage Indian medical devices manufacturers are pursuing EU MDR — CEO candidates with prior MDR-NB sustained-compliance leadership are materially more valuable. The transition from MDD to MDR has disqualified many Indian manufacturers from EU markets; the CEO who has navigated that transition successfully is rare.
What does MeitY PLI scheme participation signal for medical devices CEO mandates?
The PLI scheme has anchored ~26 manufacturers across four notified Medical Devices Parks. CEO candidates from PLI-participating manufacturers carry concrete capital-deployment-and-incentive-claims governance experience that non-PLI candidates do not — relevant for boards considering greenfield expansion under similar incentive frameworks.
Which sub-categories of medical devices does Gladwin cover for CEO search?
Cardiac (stents, pacemakers, cath-lab), orthopaedic (implants, trauma), imaging (CT, MRI, ultrasound), in-vitro diagnostics (IVD), surgical robotics, infusion-and-injection, anaesthesia-and-respiratory, ophthalmology, and disposables-and-consumables. Each sub-category has distinct regulatory and channel dynamics; Anandh's calibration segregates them.
How does Gladwin handle dual-government (FCPA + Indian compliance) reference cycles for foreign-OEM India MD candidates?
Built into the 90-day cycle. Anandh's research includes documented FCPA-clean track record (any prior FCPA event surfaces in deep referencing), and the global-HQ compliance-officer interface is engaged before slate convergence rather than after offer.
Are surgical-robotics India MD mandates served by the same bench as imaging India MD mandates?
Partially. Top surgical-robotics India MDs typically come from imaging-systems or large-cap orthopaedic-implants backgrounds — both share hospital-key-account selling and capital-equipment financing dynamics. The R&D and product-roadmap orientation differs but the commercial archetype overlaps substantially.
Where is the deepest Indian-manufacturer medical devices CEO bench?
Chennai (Trivitron, Forus Health and Tamil Nadu Medical Devices Park), Bengaluru (medical-devices-and-IVD cluster), Hyderabad (Skanray and Telangana Medical Devices Park), and Pune (Poly Medicure-cluster and OEM-component cluster).
Initial calibration calls are
held by Anandh himself.
Founders, sponsor-boards and promoter-group principals running Medical Devices CEO mandates are invited to reach out for a confidential conversation directly with Anandh Shanmugaraj.
Continue with Anandh's Take on GCC Mandates
Anandh has authored similar authoritative guides for adjacent gcc CEO and CXO mandates.
